Probiotics & Recovery From Gastrointestinal Surgery

Clinical Trial Summary

This prospective randomized trial is designed to test a pragmatic simple intervention in a community hospital. The trial will test the hypothesis whether patient recovery after a major elective abdominal operation can be improved and/or accelerated with postoperative use of probiotics.

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04732000` - Oxidative Stress and Surgical Recovery	Phase 2
Completed	`NCT01777841` - Mayo Clinic Health Connection Discovery Trial	N/A
Completed	`NCT03123068` - Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery	Phase 1/Phase 2

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT04732000 - Oxidative Stress and Surgical Recovery

Phase 2

Completed

NCT01777841 - Mayo Clinic Health Connection Discovery Trial

N/A

Completed

NCT03123068 - Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery

Phase 1/Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04266106
Study type	Interventional
Source	MercyOne Des Moines Medical Center
Contact	Jan Franko
Phone	5152473266
Email	jfranko@mercydesmoines.org
Status	Not yet recruiting
Phase	Phase 3
Start date	February 2020
Completion date	October 2021

Probiotics and Recovery From Gastrointestinal Surgery - 2 — PROGRESS-2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms